Ken Griffin acquired 708 Thousand Celldex Therapeutics shares worth $13.8 Million. That's 0.01% of their equity portfolio (1004th largest holding). The investor owns 1.01% of the outstanding Celldex Therapeutics stock. The first Celldex Therapeutics trade was made in Q4 2019. Since then Ken Griffin bought shares eleven more times and sold shares on eight occasions. The investor's estimated purchase price is $24.4 Million, resulting in a loss of 43%.